GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS IN OBESE PATIENTS WITHOUT DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Descargar Publicación
GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity The ‘Obesity First’ approach: Redefining the future of healthcare